NEW YORK, July 9 (Reuters) - Shares of Rigel Pharmaceuticals (RIGL.O) rose 29 percent to $14.50 in premarket trading on Thursday, after the company said its arthritis drug was showing progress.
For details see [ID:nBNG491740]. (Reporting by Ryan Vlastelica; Editing by James Dalgleish)
WASHINGTON (Reuters) - Senate Democrats cleared the last 60-vote hurdle on President Barack Obama's healthcare overhaul on Wednesday, virtually ensuring final passage of its version of the biggest health policy changes in four decades.
Ask an investment banker about mergers and acquisitions in 2010, and the optimism is infectious. But will the fever catch on? Commentary
It might not shake up the industry just yet, but China's interest in Volvo and Saab is the start of something big in global autos. Commentary | Video
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
